← Back to Search

Device

Washington Study of AxoTrack-Guided Central Venous Cannulation (WASHCAN Trial)

N/A
Waitlist Available
Led By Graham Nichol, MD, MPH
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 0-30 minutes
Awards & highlights
No Placebo-Only Group

Summary

Undifferentiated hypotension is a medical emergency where a patient's blood pressure drops to critical levels due to several possible reasons. The medical staff treating the patient will need to find out the reason for your drop in blood pressure as soon as possible. When treating low blood pressure, the medical staff typically performs a procedure called central venous cannulation (CVC). CVC involves accessing a large vein (usually the subclavian under the collarbone) by inserting a needle into the vein. By doing this, the medical staff can measure the pressures in the patient's veins or give medicine to the patient while they are in the hospital. The purpose of this study is to compare the time needed to complete CVC using the AxoTrack device to CVC guided by landmarks on a patient's body. The investigators expect that there will be a maximum of 30 patients enrolled in this study.

Eligible Conditions
  • Low Blood Pressure

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0-30 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 0-30 minutes for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Time to insertion of CVC into a subclavian vein

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: AxoTrack System guided CVC insertionExperimental Treatment1 Intervention
AxoTrack System guided CVC
Group II: CVC insertion guided by landmarkActive Control1 Intervention
Anatomical landmarks to guide CVC

Find a Location

Who is running the clinical trial?

University of WashingtonLead Sponsor
1,827 Previous Clinical Trials
1,906,814 Total Patients Enrolled
Graham Nichol, MD, MPHPrincipal InvestigatorUniversity of Washington
1 Previous Clinical Trials
30 Total Patients Enrolled
~0 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top